LINGYE

Serial Number 97284409
602

Registration Progress

Application Filed
Feb 25, 2022
Under Examination
Approved for Publication
Published for Opposition
Registered

Basic Information

Serial Number
97284409
Filing Date
February 25, 2022
Abandonment Date
March 10, 2023
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Mar 27, 2023
Classes
005 042

Rights Holder

Hangzhou SoliPharma Co., Ltd.

99
Address
260 6th Ave, Bldg 1, 1st F
Qiantang New Area
Hangzhou, Zhejiang 310018
CN

Ownership History

Hangzhou SoliPharma Co., Ltd.

Original Applicant
99
Hangzhou, Zhejiang CN

Legal Representation

Attorney
Lawrence E. Apolzon

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

9 events
Date Code Type Description
Mar 27, 2023 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 27, 2023 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Mar 27, 2023 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Dec 9, 2022 DOCK D ASSIGNED TO EXAMINER
Dec 9, 2022 CNRT R NON-FINAL ACTION WRITTEN
Dec 9, 2022 GNRT F NON-FINAL ACTION E-MAILED
Dec 9, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 2, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 1, 2022 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of infectious diseases, immune system diseases and disorders, pain, allergy inflammation, alopecia, tumors, respiratory diseases, blood diseases and disorders, cognitive disorders, cardiovascular disease, blood vasculare disease, gynecological diseases, hyperproliferative disease, skin diseases, obesity, and endocrine disease; Pharmaceutical preparations and substances for the treatment of infectious diseases, immune system diseases and disorders, pain, allergy inflammation, alopecia, tumors, respiratory diseases, blood diseases and disorders, cognitive disorders, cardiovascular disease, blood vasculare disease, gynecological diseases, hyperproliferative disease, skin diseases, obesity, and endocrine disease; Drug delivery agents in the form of powders, tablets, capsules, injectable pharmaceuticals, pills, caplets, liquid drops, sachets, spray, ointment, cream, foam gel, lotion, patch, inhaler, granule, film, suspension, infusion and suppository that provide controlled release of the active ingredients for a wide variety of pharmaceuticals
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
Research and development of new products for others; Scientific research; Chemical analysis; Chemical research; Biological research; Cosmetic research; Medical research; Development of pharmaceutical preparations and medicines; Scientific research in the nature of conducting clinical trials for others; Inspection of medical equipment for quality control purposes; Chemical engineering; Technology consultation in the field of medical research; Research and development of technology in the field of medical research
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 042